20-44620200-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000022.4(ADA):​c.1078+99C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0555 in 1,067,310 control chromosomes in the GnomAD database, including 2,135 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.073 ( 547 hom., cov: 33)
Exomes 𝑓: 0.053 ( 1588 hom. )

Consequence

ADA
NM_000022.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.00400
Variant links:
Genes affected
ADA (HGNC:186): (adenosine deaminase) This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019]
PKIG (HGNC:9019): (cAMP-dependent protein kinase inhibitor gamma) This gene encodes a member of the protein kinase inhibitor family. Studies of a similar protein in mice suggest that this protein acts as a potent competitive cAMP-dependent protein kinase inhibitor, and is a predominant form of inhibitor in various tissues. The encoded protein may be involved in osteogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 20-44620200-G-A is Benign according to our data. Variant chr20-44620200-G-A is described in ClinVar as [Benign]. Clinvar id is 1173012.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.133 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADANM_000022.4 linkc.1078+99C>T intron_variant Intron 11 of 11 ENST00000372874.9 NP_000013.2 P00813A0A0S2Z381
ADANM_001322051.2 linkc.1006+99C>T intron_variant Intron 10 of 10 NP_001308980.1 F5GWI4
ADANM_001322050.2 linkc.673+99C>T intron_variant Intron 10 of 10 NP_001308979.1
ADANR_136160.2 linkn.1105+99C>T intron_variant Intron 10 of 10

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAENST00000372874.9 linkc.1078+99C>T intron_variant Intron 11 of 11 1 NM_000022.4 ENSP00000361965.4 P00813
ADAENST00000695995.1 linkc.688+99C>T intron_variant Intron 8 of 8 ENSP00000512318.1 A0A8Q3SI64
ADAENST00000695991.1 linkc.616+99C>T intron_variant Intron 7 of 7 ENSP00000512314.1 A0A0S2Z3B9
ADAENST00000695956.1 linkc.232+99C>T intron_variant Intron 2 of 2 ENSP00000512285.1 A0A8Q3WKW4
ADAENST00000696038.1 linkn.*934C>T non_coding_transcript_exon_variant Exon 9 of 9 ENSP00000512344.1 A0A8Q3SJ57
ADAENST00000696038.1 linkn.*934C>T 3_prime_UTR_variant Exon 9 of 9 ENSP00000512344.1 A0A8Q3SJ57

Frequencies

GnomAD3 genomes
AF:
0.0728
AC:
11075
AN:
152146
Hom.:
546
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.136
Gnomad AMI
AF:
0.0396
Gnomad AMR
AF:
0.0562
Gnomad ASJ
AF:
0.0784
Gnomad EAS
AF:
0.00211
Gnomad SAS
AF:
0.0615
Gnomad FIN
AF:
0.0420
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0494
Gnomad OTH
AF:
0.0721
GnomAD4 exome
AF:
0.0526
AC:
48167
AN:
915046
Hom.:
1588
AF XY:
0.0532
AC XY:
25415
AN XY:
478098
show subpopulations
Gnomad4 AFR exome
AF:
0.137
AC:
3131
AN:
22830
Gnomad4 AMR exome
AF:
0.0710
AC:
3089
AN:
43536
Gnomad4 ASJ exome
AF:
0.0767
AC:
1743
AN:
22736
Gnomad4 EAS exome
AF:
0.000537
AC:
20
AN:
37210
Gnomad4 SAS exome
AF:
0.0622
AC:
4667
AN:
75004
Gnomad4 FIN exome
AF:
0.0458
AC:
2403
AN:
52432
Gnomad4 NFE exome
AF:
0.0490
AC:
30196
AN:
615788
Gnomad4 Remaining exome
AF:
0.0610
AC:
2583
AN:
42352
Heterozygous variant carriers
0
2596
5192
7787
10383
12979
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
792
1584
2376
3168
3960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0728
AC:
11091
AN:
152264
Hom.:
547
Cov.:
33
AF XY:
0.0717
AC XY:
5339
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.136
AC:
0.135821
AN:
0.135821
Gnomad4 AMR
AF:
0.0561
AC:
0.0561224
AN:
0.0561224
Gnomad4 ASJ
AF:
0.0784
AC:
0.0783862
AN:
0.0783862
Gnomad4 EAS
AF:
0.00212
AC:
0.00211946
AN:
0.00211946
Gnomad4 SAS
AF:
0.0613
AC:
0.061309
AN:
0.061309
Gnomad4 FIN
AF:
0.0420
AC:
0.0420041
AN:
0.0420041
Gnomad4 NFE
AF:
0.0494
AC:
0.0494192
AN:
0.0494192
Gnomad4 OTH
AF:
0.0718
AC:
0.0718336
AN:
0.0718336
Heterozygous variant carriers
0
533
1066
1598
2131
2664
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0721
Hom.:
70
Bravo
AF:
0.0777
Asia WGS
AF:
0.0400
AC:
140
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.4
DANN
Benign
0.63
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs45567734; hg19: chr20-43248841; API